Clinical Trial Update: Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial of GSK1070806 for prevention of delayed graft function in adult kidney transplant recipients; study terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• GSK1070806

Snippet

Sponsor: GlaxoSmithKline | Conditions: Kidney Transplantation (Status Post) | Phase 2 | Status: TERMINATED | Results posted: 2019-06-10